1. We must be very careful & manage people's expectation regarding the Covid vaccine : Adar Poonawalla  ThePrint
  2. How One Indian Company Could Be World's Door to a COVID-19 Vaccine  The New York Times
  3. INSIGHT-How one Indian company could be world's door to a COVID-19 vaccine  Yahoo Finance
  4. If AstraZeneca & Oxford trials are safe we could have a potential vaccine at the end of the year  ThePrint
  5. Covid-19 Vaccine Development at Early Stage in India But Breakthrough Unlikely Within a Year  News18
  6. View Full coverage on Google News
If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.

If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentiallyIf the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially

INSIGHT-How one Indian company could be world's door to a COVID-19 vaccine

LONDON: A team of researchers has begun recruiting volunteers for clinical trials of a vaccine against COVID-19, while another team has started work on a treatment that may help critically ill patients recover from the disease.LONDON: A team of researchers has begun recruiting volunteers for clinical trials of a vaccine against COVID-19, while another team has started work on a treatment that may help critically ill

Researchers begin trials of COVID-19 vaccine | Arab News

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Glasgow joins crucial trials to test coronavirus vaccine https://t.co/HgZFUd7KxR”

Stewart McDonald MP on Twitter: "Glasgow joins crucial trials to test coronavirus vaccine https://t.co/HgZFUd7KxR"

“5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS”

Mariana Mazzucato on Twitter: "5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS"

“Nobody has been more supportive of @UniofOxford #Coronavirus vaccine than I, but why are five year old children, who cannot possibly consent, being given an experimental vaccine, even in a second stage trial? Neither @BBCNews nor the University's website explains”

Louise Mensch on Twitter: "Nobody has been more supportive of @UniofOxford #Coronavirus vaccine than I, but why are five year old children, who cannot possibly consent, being given an experimental vaccine, even in a second stage trial? Neither @BBCNews nor the University's website explains"

Serum Institute chief says the potential vaccine is based on a tried-and-tested platformSerum Institute chief says the potential vaccine is based on a tried-and-tested platform

Coronavirus | 80% success chance for Oxford vaccine trials, says Serum Institute chief - The Hindu

Serum Institute, the world’s largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus, including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines.Serum Institute, the world’s largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus, including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines.

How one Indian company could be world’s door to a Covid-19 vaccine - india news - Hindustan Times

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university.Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university.

How One Indian Company in Pune Could be The World's Door to a Coronavirus Vaccine

Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and industry have come together in cutting-edge vaccine design and development. Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and industry have come together in cutting-edge vaccine design and development.

COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year: Experts - The Economic Times

Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and industry have come together in cutting-edge vaccine design and development.

COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year: Experts - The Economic Times

Health: INSIGHT: How one Indian company could be world's door to a Covid-19 vaccine

The company will get up to $1.2 billion from the US Department of Health and Human Services to speed the development and production of the vaccine.The feds have ordered 300 million doses of a potential coronavirus vaccine from British drugmaker AstraZeneca, officials said Thursday. The company will get up to $1.2 billion from the US Department

US orders 300M doses of AstraZeneca's coronavirus vaccine

If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. For latest updates and live news on coronavirus, click hereIf the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. For latest updates and live news on coronavirus, click here

Coronavirus: How one Indian company could be world's door to a COVID-19 vaccine | Deccan Herald

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.The Serum Institute produces more than 1.5 billion doses of vaccines every year, for everything from polio to measlesSerum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.The Serum Institute produces more than 1.5 billion doses of vaccines every year, for everything from polio to measles

How one Indian company could be world's door to a Covid-19 vaccine

Serum Institute has partnered with U.S. biotech firm Codagenix, its U.S. rival Novavax and Austria's Themis to potentially manufacture three COVID-19 vaccine candidates that are still in developmentSerum Institute has partnered with U.S. biotech firm Codagenix, its U.S. rival Novavax and Austria's Themis to potentially manufacture three COVID-19 vaccine candidates that are still in development

Coronavirus vaccine: How Serum Institute could be world's door

As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthroughAs Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough

COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year, say experts | Business Insider India

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.

An Indian company could be world's door to a Covid-19 vaccine - News | Khaleej Times

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines - as well as developing its own.Get latest Healthcare online at cnbctv18.com Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines - as well as developing its own.Get latest Healthcar

How this Indian company could be world's door to a COVID-19 vaccine - cnbctv18.com

At the company's sprawling, 150-acre campus in the western Indian city of Pune, Shaligram and his team are working flat-out..Serum Institute. Pune-based firm. COVID-19 vaccine. coronavirus vaccine.Business News. Finance NewsAt the company's sprawling, 150-acre campus in the western Indian city of Pune, Shaligram and his team are working flat-out..Serum Institute. Pune-based firm. COVID-19 vaccine. coronavirus vaccine.Business News. Finance News

How a Pune-based firm may open the world's door to a COVID-19 vaccine | Business News | English Manorama